These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7478523)

  • 1. Characterization of RET proto-oncogene 3' splicing variants and polyadenylation sites: a novel C-terminus for RET.
    Myers SM; Eng C; Ponder BA; Mulligan LM
    Oncogene; 1995 Nov; 11(10):2039-45. PubMed ID: 7478523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Drosophila Ret gene is transcribed in multiple alternatively spliced forms.
    Huen DS; Elsdon M; Ponder BA
    Mol Gen Genet; 2000 Oct; 264(3):335-40. PubMed ID: 11085274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.
    Beldjord C; Desclaux-Arramond F; Raffin-Sanson M; Corvol JC; De Keyzer Y; Luton JP; Plouin PF; Bertagna X
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservation of RET proto-oncogene splicing variants and implications for RET isoform function.
    Carter MT; Yome JL; Marcil MN; Martin CA; Vanhorne JB; Mulligan LM
    Cytogenet Cell Genet; 2001; 95(3-4):169-76. PubMed ID: 12063395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line.
    Tahira T; Ishizaka Y; Itoh F; Sugimura T; Nagao M
    Oncogene; 1990 Jan; 5(1):97-102. PubMed ID: 2181380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas.
    Fluge O; Haugen DR; Akslen LA; Marstad A; Santoro M; Fusco A; Varhaug JE; Lillehaug JR
    Oncogene; 2001 Feb; 20(7):885-92. PubMed ID: 11314023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple mRNA isoforms of the human RET proto-oncogene generated by alternate splicing.
    Lorenzo MJ; Eng C; Mulligan LM; Stonehouse TJ; Healey CS; Ponder BA; Smith DP
    Oncogene; 1995 Apr; 10(7):1377-83. PubMed ID: 7731689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exon structure and flanking intronic sequences of the human RET proto-oncogene.
    Ceccherini I; Bocciardi R; Luo Y; Pasini B; Hofstra R; Takahashi M; Romeo G
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1288-95. PubMed ID: 7902707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3' Splicing variants of ret receptor tyrosine kinase are differentially expressed in mouse embryos and in adult mice.
    Lee KY; Samy ET; Sham MH; Tam PK; Lui VC
    Biochim Biophys Acta; 2003 May; 1627(1):26-38. PubMed ID: 12759189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cDNA sequence and genomic structure of the rat RET proto-oncogene.
    Matera I; De Miguel-Rodríguez M; Fernández-Santos JM; Santamaria G; Puliti A; Ravazzolo R; Romeo G; Galera-Davidson H; Ceccherini I
    DNA Seq; 2000; 11(5):405-17. PubMed ID: 11328649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.
    Takahashi M; Buma Y; Iwamoto T; Inaguma Y; Ikeda H; Hiai H
    Oncogene; 1988 Nov; 3(5):571-8. PubMed ID: 3078962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of multiple isoforms of the ELKS mRNAs involved in a papillary thyroid carcinoma.
    Nakata T; Yokota T; Emi M; Minami S
    Genes Chromosomes Cancer; 2002 Sep; 35(1):30-7. PubMed ID: 12203787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5'-End RET splicing: absence of variants in normal tissues and intron retention in pheochromocytomas.
    Le Hir H; Charlet-Berguerand N; de Franciscis V; Thermes C
    Oncology; 2002; 63(1):84-91. PubMed ID: 12187076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promiscuity of pre-mRNA spliceosome-mediated trans splicing: a problem for gene therapy?
    Kikumori T; Cote GJ; Gagel RF
    Hum Gene Ther; 2001 Jul; 12(11):1429-41. PubMed ID: 11485634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RET proto-oncogene point mutations in sporadic neuroendocrine tumors.
    Komminoth P; Roth J; Muletta-Feurer S; Saremaslani P; Seelentag WK; Heitz PU
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2041-6. PubMed ID: 8964826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
    Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
    Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analysis of the human ret proto-oncogene using exon trapping.
    Kwok JB; Gardner E; Warner JP; Ponder BA; Mulligan LM
    Oncogene; 1993 Sep; 8(9):2575-82. PubMed ID: 8361767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing of the ret proto-oncogene at intron 4.
    Xing S; Tong Q; Suzuki T; Jhiang SM
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1526-32. PubMed ID: 7811232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of RET oncogene in human adrenal tumors.
    Lin SR; Yang YC; Tsai JH; Hsu CH
    Jpn J Cancer Res; 1998 Jun; 89(6):634-40. PubMed ID: 9703361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.